'Progressive multifocal leukoencephalopathy' diaporamas de présentation

???? ????

1.1k views • 49 slides

Rituximab (RITUXAN) & Multiple Sclerosis

Rituximab (RITUXAN) & Multiple Sclerosis . Dr. Andrew Sylvester Attending Neurologist, IMSMP Assistant Clinical Scientist, MSRCNY. What is Rituximab?. Trade name = Rituxan Monoclonal antibody Suppresses the immune system Targets & depletes B-cells from the blood

2.01k views • 23 slides

7.1a. Contrast axial T1 Wtd MRI

7.1a. Contrast axial T1 Wtd MRI. 7.1b. Contrast coronal T1 Wtd MRI. 7.1c. Contrast sagittal T1 Wtd MRI. Figure 7.1: An enhancing ring lesion within the left posterior frontal lobe. Diagnosis:. Pyogenic Abscess Differential diagnosis : Metastasis

256 views • 8 slides

7.1a. Contrast axial T1 Wtd MRI

7.1a. Contrast axial T1 Wtd MRI. 7.1b. Contrast coronal T1 Wtd MRI. 7.1c. Contrast sagittal T1 Wtd MRI. Figure 7.1: An enhancing ring lesion within the left posterior frontal lobe. Diagnosis:. Pyogenic Abscess Differential diagnosis : Metastasis

331 views • 8 slides

nrrheum.2014.167 pf1

Figure 1 Infection with JC virus is at first asymptomatic and presumably occurs at an early age by oral route. Calabrese, L. H. et al. (2014) Sorting out the risks in progressive multifocal leukoencephalopathy Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.167.

171 views • 1 slides

Table 1 Classification of immunosuppressive therapies by PML risk

Table 1 Classification of immunosuppressive therapies by PML risk. Calabrese, L. H. et al. (2014) Sorting out the risks in progressive multifocal leukoencephalopathy Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.167.

131 views • 1 slides